Class 1. Drug-induced and Toxin-induced Pulmonary Hypertension

Vascular and pulmonary effects of ibuprofen on neonatal lung development

Xueyu Chen, Dongshan Han, Xuan Wang, Xuemei Huang, Zilu Huang, Yijun Liu, Junyan Zhong, Frans J. Walther, Chuanzhong Yang, Gerry T. M. WagenaarAffiliated Shenzhen Maternity and Child Healthcare Hospital, The First School of Clinical Medicine, Southern Medical University. David Geffen School of Medicine, University of California Los Angeles. Lundquist Institute for Biomedical Innovation at Harbor-UCLA […]

Vascular and pulmonary effects of ibuprofen on neonatal lung development Read More »

Pulmonary Hypertension and Necrotizing Enterocolitis in Neonates Treated with Diazoxide

Mounya Duggal, Shiran S. Moore, Jessica Simoneau, Gabrielle Girard, Irene B. Gernet, Julia E. Von Oettingen, GuilhermeSant’Anna, Gabriel AltitMcGill University and Montreal Children’s Hospital. Canada American Journal of PerinatologyAm J Perinatol 2023; DOI: 10.1055/s-0043-1764385 AbstractObjective: This study aimed to evaluate the prevalence of adverse outcomes, specifically pulmonary hypertension (PH) and suspected or confirmed necrotizing enterocolitis (NEC), and

Pulmonary Hypertension and Necrotizing Enterocolitis in Neonates Treated with Diazoxide Read More »

Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity

Christopher R. Nitkin, Nicholas A. Bamat, Joanne Lagatta, Sara B. DeMauro, Henry C. Lee, Ravi Mangal Patel, Brian King, Jonathan L. Slaughter, J. Peter Campbell, Troy Richardson, Tamorah LewisUniversity of Missouri Kansas City School and Children’s Mercy Hospital. University of Pennsylvania and Children’s Hospital of Philadelphia. Medical College of Wisconsin. Stanford University. Emory University and

Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity Read More »

Scroll to Top